GlassScriptPhysician profile
Maria E Pina
NPI 1518934074
$710.03
in general payments reported to CMS, 2019-2025
14 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $96.91 · 2023: $49.66 · 2024: $350 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $141.62 | 2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Tezspire |
| Hologic Sales and Service, LLC | $111.89 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Novo Nordisk INC | $83.48 | 2024 | Wegovy |
| Ucb, INC. | $65.86 | 2020 | |
| Integra Lifesciences Corporation | $49.66 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Astellas Pharma US INC | $22.16 | 2019 | |
| Radius Health, INC. | $18.04 | 2019 | |
| Vanda Pharmaceuticals INC. | $17.78 | 2020 | |
| Shire North American Group INC | $16.58 | 2019 | |
| Merck Sharp & Dohme LLC | $15.68 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.77 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.24 | 2019 | |
| Allergan, INC. | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Pina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.